Related by context. All words. (Click for frequent words.) 76 TELINTRA 74 TLK# 73 tanespimycin 73 phase IIb clinical 72 Targretin 72 Telcyta 72 ganetespib 72 elotuzumab 71 MAGE A3 ASCI 71 Traficet EN 71 Fludara 71 docetaxel Taxotere ® 70 DAVANAT 70 HGS ETR1 70 HGS ETR2 70 valopicitabine 70 TORISEL 70 alvespimycin 70 mapatumumab 70 LEP ETU 70 Amrubicin 69 Alocrest 69 SinuNase TM 69 custirsen 69 BAY #-# 69 KNS # 69 docetaxel Taxotere R 69 ZYBRESTAT fosbretabulin 69 CA4P 69 cetuximab Erbitux R 69 dasatinib Sprycel ® 69 Fibrillex TM 69 Proxinium TM 69 huC# DM4 69 dacetuzumab 69 trastuzumab DM1 T DM1 69 Gemzar ® 69 OPAXIO 69 Dacogen injection 69 nilotinib 69 PROMACTA 69 glufosfamide 69 pomalidomide 69 neratinib 69 Azedra 69 axitinib 69 sorafenib tablets 68 forodesine 68 Telik logo TELINTRA 68 Xanafide 68 zalutumumab 68 Telintra 68 oral ridaforolimus 68 erlotinib Tarceva ® 68 Bezielle 68 EOquin 68 refractory chronic lymphocytic 68 relapsed refractory multiple myeloma 68 SinuNase 68 #D#C# 68 thymalfasin 68 refractory gout 68 crizotinib PF # 68 Tarceva TM 68 telbivudine 68 ADVEXIN 68 MGCD# [001] 68 cetuximab Erbitux ® 68 Marqibo 68 Panzem R NCD 68 BRIM2 68 TYKERB 68 sunitinib malate 68 pertuzumab 68 EndoTAG TM -1 68 EOquin TM 68 mertansine 68 TELCYTA TM TLK# 68 IL# PE#QQR 68 INCB# [001] 68 MyVax R 68 vandetanib 68 ONTAK 68 dextromethorphan quinidine 68 lapatinib Tykerb 67 posaconazole 67 OvaRex ® MAb 67 Phenoptin 67 Specifid 67 Ixempra 67 HspE7 67 investigational monoclonal antibody 67 assessing T DM1 67 PEG SN# 67 rindopepimut 67 Stedivaze 67 EDEMA3 67 carboplatin paclitaxel 67 vinorelbine 67 TRISENOX ® 67 PDX pralatrexate 67 HGS# 67 alvimopan 67 LymphoStat B 67 Cloretazine 67 docetaxel chemotherapy 67 Anturol 67 Sym# 67 evaluating tivozanib 67 CIMZIA ™ 67 sorafenib Nexavar 67 AzaSite Plus 67 CIMZIA TM 67 galiximab 67 oral prodrug 67 Cloretazine R VNP#M 67 Pegasys ® 67 TYZEKA 67 AVASTIN 67 metastatic CRC 67 CANCIDAS 67 AQ4N 67 subcutaneous formulation 67 YONDELIS 67 FOLOTYN ® 67 ZOLINZA 67 elacytarabine 67 bevacizumab Avastin ® 67 IMA# 67 HCV RESPOND 2 67 comparator arm 67 Aflibercept 67 CINTREDEKIN BESUDOTOX 67 active comparator 67 lenalidomide Revlimid R 67 Phase Ib clinical trials 67 mycophenolate mofetil 67 VELCADE melphalan 67 ponatinib 67 phase IIb 67 RhuDex ® 67 romidepsin 67 phase III isavuconazole 67 CoFactor 67 UPLYSO 67 phase IIa clinical 67 obatoclax 66 GRNVAC1 66 virus HCV protease inhibitor 66 Tarceva erlotinib 66 lintuzumab 66 PS# [001] 66 Phase Ib clinical 66 brivaracetam 66 Asentar 66 Xcytrin R 66 Tavocept 66 Phase #b/#a clinical 66 teriflunomide 66 tafamidis 66 Fludara ® 66 ZACTIMA 66 dose cohort 66 Hyphanox 66 sipuleucel T 66 IMC A# 66 HuMax EGFr 66 interferon gamma 1b 66 trastuzumab Herceptin R 66 SUTENT 66 alfa 2a 66 metastatic GIST 66 Virulizin R 66 KRN# 66 PRE SURGE 66 teduglutide 66 Allovectin 7 R 66 novel VDA molecule 66 Excellarate 66 gefitinib Iressa 66 Glufosfamide 66 Omigard 66 adalimumab Humira 66 cutaneous T cell 66 ribavirin RBV 66 Phase IIIb clinical 66 GATTEX ® 66 Aurexis 66 ACTEMRA TM 66 EFAPROXYN 66 enzastaurin 66 celgosivir 66 PANVAC VF 66 BCX# 66 Viramidine 66 Pivotal Phase III 66 opioid induced bowel dysfunction 66 Cleviprex TM clevidipine 66 Aplidin R 66 ORENCIA ® 66 TBC# 66 nab paclitaxel 66 fosbretabulin 66 rNAPc2 66 palonosetron 66 Onalta ™ 66 refractory multiple myeloma 66 JAK inhibitor 66 Atrasentan 66 refractory Hodgkin lymphoma 66 ularitide 66 trabectedin 66 temsirolimus 66 FOLOTYN 66 FOLPI 66 decitabine 66 OncoVEX GM CSF 66 dirucotide 66 Panzem R 66 MYDICAR 66 CBLC# 66 REVLIMID R 66 Nexavar ® 66 vidofludimus 66 cediranib 66 PREOS 66 HuMax CD4 66 sunitinib Sutent ® 66 reslizumab 66 Pemetrexed 66 HuLuc# 66 REVLIMID lenalidomide 65 CB2 selective receptor agonist 65 Tamibarotene 65 PXD# 65 bosutinib 65 Amplimexon 65 Azedra ™ 65 AEG# 65 XL# SAR# 65 PRT# 65 Pivotal Phase 65 CIMZIA TM certolizumab pegol 65 ALN TTR# 65 RG# [001] 65 NEUPOGEN 65 ALVESCO R 65 sodium thiosulfate STS 65 lintuzumab SGN 65 tramiprosate Alzhemed TM 65 Cloretazine ® 65 T DM1 65 CD3 monoclonal antibody 65 TELCYTA R 65 Seliciclib 65 PEG PAL 65 DEB# 65 amrubicin 65 Clolar ® 65 Phase III Pivotal 65 Phase Ib study 65 cilengitide 65 Hycamtin 65 nitazoxanide 65 Besivance 65 sapacitabine 65 Zenvia ™ 65 Prosaptide 65 pradefovir 65 Rebif ® 65 Phase IIb trials 65 Raptiva ® 65 FOLFOX4 65 PEGINTRON TM 65 Triolex 65 Ocrelizumab 65 Androxal TM 65 budesonide foam 65 urocortin 2 65 ruxolitinib 65 R#/MEM # 65 PrevOnco 65 registrational trial 65 ocrelizumab 65 liposomal doxorubicin 65 T Pred 65 standard chemotherapy regimen 65 bevacizumab Avastin 65 TRISENOX 65 Entereg R 65 romiplostim 65 incyclinide 65 INVANZ 65 Elagolix 65 clodronate 65 pralatrexate 65 telaprevir VX 65 ICA # 65 YERVOY 65 panitumumab Vectibix 65 vicriviroc 65 Taxotere ® 65 IAP inhibitor 65 cinacalcet HCl 65 CCX# 65 peginterferon alfa 65 investigational protease inhibitor 65 blinatumomab 65 OXi# 65 Ereska 65 MGd 65 HQK 65 Genasense 65 chlorambucil 65 non nucleoside HCV 65 lesinurad 65 GSK# [001] 65 Zelrix 65 Chrysalin 65 picoplatin 65 FavId 65 Vicinium TM 65 baminercept 65 XL# XL# XL# 65 aflibercept 65 eltrombopag 65 low dose cytarabine 65 6R BH4 65 Xcellerated T Cells 65 cell lymphoma CTCL 65 Elotuzumab 65 bevacizumab Avastin R 65 randomized Phase IIb 65 LAF# 65 PREZISTA r 65 confirmatory Phase III 65 CYT# potent vascular disrupting 65 Insegia 65 adecatumumab 65 ISENTRESS 65 TO AVOID PREGNANCY WHILE 65 MYCAMINE 65 rhThrombin 65 LEUKINE 65 oxymorphone ER 65 dasatinib Sprycel 65 Fodosine 65 cannabinor 65 Zemiva ™ 65 Copegus ribavirin 65 FOLFIRI 65 IMGN# 65 R sorafenib tablets 65 ROTATEQ 65 bicifadine 65 Vectibix 65 dacarbazine 65 imatinib mesylate Gleevec 65 Nuvion 65 tamibarotene 65 Capesaris 65 radiation sensitizer 65 Taxotere R 65 daclizumab 65 Phase 2b clinical 64 Phase 2a trial 64 Mylotarg 64 maximally tolerated dose 64 ORENCIA R 64 Solazed TM 64 visilizumab 64 Phase #b/#a 64 esophageal candidiasis 64 imatinib resistant 64 placebo controlled Phase 64 MabCampath 64 AEGR 64 tigecycline 64 bortezomib Velcade R 64 APTIVUS 64 Navelbine ® 64 GOUT 64 Aptivus ® 64 JZP 64 Hepatocellular Carcinoma HCC 64 rilonacept 64 Daclizumab 64 BrachySil 64 INTELENCE 64 dose escalation Phase 64 HCD# [002] 64 MYLOTARG 64 pegylated liposomal doxorubicin 64 PSMA ADC 64 tivozanib 64 thalidomide Thalomid 64 HGS ETR1 mapatumumab 64 multicenter Phase 64 Apoptone 64 ixabepilone 64 Vandetanib 64 Chemophase 64 treatment naive genotype 64 nilotinib Tasigna ® 64 phase IIb study 64 DAPT 64 ELACYT 64 ALGRX 64 cangrelor 64 Troxatyl 64 Rasilez Tekturna 64 erlotinib Tarceva R 64 investigational antiplatelet agent 64 proteasome inhibitor 64 canakinumab 64 Pradefovir 64 BRIM3 64 GAMMAGARD 64 Sandostatin LAR 64 Velcade bortezomib 64 paclitaxel Taxol ® 64 atacicept 64 Vidaza R 64 satraplatin 64 Zolinza 64 lumiliximab 64 CD# monoclonal antibody 64 TheraCIM 64 HEPLISAV TM 64 TRANSDUR Sufentanil 64 unique alkylating agent 64 MyVax personalized immunotherapy 64 XYOTAX TM 64 Ophena 64 Oral NKTR 64 Gabapentin GR 64 gemcitabine cisplatin 64 motesanib 64 Allovectin 7 ® 64 menadione 64 phase Ib 64 DOXIL 64 Aplidin 64 MOZOBIL 64 Cannabinor 64 receptor tyrosine kinase inhibitor 64 refractory metastatic colorectal cancer 64 talactoferrin 64 Bicifadine 64 Ophena TM 64 Triapine R 64 systemic anaplastic large 64 Pimavanserin 64 acyclovir Lauriad R 64 MKC# MT 64 ocular formulation 64 Archexin 64 HuMax CD# 64 oral rivaroxaban 64 INC# 64 zanolimumab 64 pan HDAC inhibitor 64 Xeloda ® 64 renal toxicity 64 liposomal formulation 64 ENMD # 64 fluoropyrimidine 64 modified glutathione analog 64 ISTODAX 64 TOCOSOL Paclitaxel 64 plus gemcitabine 64 SPRYCEL ® 64 randomized multicenter Phase III 64 TRIOLEX 64 platinum refractory 64 Vitaxin 64 pamidronate 64 L BLP# 64 Arranon 64 PNP inhibitor 64 RELOVAIR ™ 64 Veronate 64 pentadentate logo R 64 Randomized Phase 64 CD# CEA 64 Plicera 64 peginterferon alfa 2a Pegasys 64 COPEGUS 64 rALLy clinical trial 64 nonclinical studies 64 PEGylated anti 64 Kepivance 64 Exherin TM 64 XmAb# 64 ELADUR 64 Dual Opioid 64 REMICADE ® 64 talabostat 64 Initiated Phase 64 Symadex 64 azacitidine 64 Augment Injectable 64 squalamine 64 Phase IIIb 64 FASLODEX 64 perifosine 64 LY# [003] 64 Peg IFN 64 Quinamed 64 LymphoStat B belimumab 64 goserelin 64 ongoing Phase 1b 64 fenofibric acid 64 mTOR inhibitors 64 ZYBRESTAT 64 Carfilzomib 64 multicenter Phase III 64 PLK1 SNALP 64 Zorbtive TM 64 metastatic HRPC 64 bicalutamide 64 ACTEMRA 64 lucinactant 64 ProSavin 64 TKM ApoB 64 Cethrin 64 infusional 5-FU/LV 64 PSN# [002] 64 phase IIIb 64 recurrent glioblastoma multiforme 64 sargramostim 64 panitumumab 64 caspofungin 64 systemic ALCL 64 cutaneous T 64 recurrent NSCLC 64 ARIMIDEX 64 Alfimeprase 64 certolizumab 64 dasatinib 64 Ambrisentan 64 Cetuximab Erbitux 64 alemtuzumab Campath 64 Panzem NCD 64 etanercept Enbrel 64 FUSILEV ® 64 HER2 positive metastatic breast 64 Advexin 64 Torisel 64 catheter occlusion 64 entinostat 64 plus dexamethasone 64 CERVARIX 64 Genasense ® 64 elagolix 64 SAR# [004] 64 Proellex TM 64 Doxil ® 64 evaluating Xcytrin 64 arsenic trioxide injection 63 Phase #b/#a trial 63 Phase 1b clinical 63 budesonide MMX 63 Neulasta ® 63 Allovectin 7 63 pharmacokinetic PK study 63 Zemiva TM 63 AeroLEF TM 63 depsipeptide 63 Gliadel Wafer 63 R lenalidomide 63 telaprevir dosed 63 Personalized Immunotherapy 63 dose cohorts 63 TAXOTERE R 63 GVAX immunotherapy 63 Panzem 63 BRAF inhibitor 63 tolevamer 63 oral FTY# 63 methylnaltrexone bromide 63 Locteron 63 cintredekin besudotox 63 PEG INTRON 63 orBec 63 XELOX 63 DXL# 63 gemcitabine carboplatin 63 RGB # 63 anti leukemic 63 adriamycin 63 Noxafil 63 Nexavar sorafenib 63 IMiDs 63 vosaroxin 63 nucleoside analogues 63 Eloxatin R 63 VNP#M 63 Raptiva R 63 5 fluorouracil leucovorin 63 oral deforolimus 63 Aryplase 63 ELND# 63 Generx TM 63 Bortezomib 63 ARIKACE 63 hypoxia activated prodrug 63 Actilon 63 Azedra TM 63 RAPAMUNE 63 relapsed MM 63 Dasatinib 63 relapsed myeloma 63 NOXAFIL 63 palifermin 63 ApoB SNALP 63 AVE# 63 somatostatin analogue 63 Golimumab 63 DexaSite 63 Civacir 63 cetuximab Erbitux 63 Excellagen 63 fluvastatin 63 diabetic neuropathic pain 63 Xyfid TM 63 SILENOR TM 63 double blinded placebo 63 IMC #B 63 Reolysin 63 Jevtana 63 tramiprosate 63 phase IIa 63 belinostat 63 octreotide acetate 63 GW# [003] 63 echinocandin 63 registrational 63 CORT # 63 NATRECOR R 63 FOLFOX 63 antibody MAb 63 Zerenex 63 Irinotecan 63 NP2 Enkephalin 63 Phase Ib 63 Tyrima 63 pegfilgrastim 63 imatinib Gleevec ® 63 ofatumumab HuMax CD# 63 methylnaltrexone 63 relapsed multiple myeloma 63 AzaSite Xtra 63 iniparib 63 PegIntron 63 prucalopride 63 UVIDEM 63 5 FU leucovorin 63 erlotinib Tarceva 63 inhibitor RG# 63 alpha interferons 63 HCV SPRINT 63 estramustine 63 Dalbavancin 63 Solazed ™ 63 Phase IIa trial 63 bazedoxifene 63 LEVAQUIN 63 AGILECT R 63 TREDAPTIVE 63 Adalimumab 63 histone deacetylase HDAC inhibitor 63 riociguat 63 Anturol TM 63 TREANDA 63 selective androgen receptor modulator 63 boosted protease inhibitor 63 nalbuphine ER 63 micafungin 63 BiovaxID TM 63 Dacogen decitabine 63 G#DT 63 Phase 1b clinical trials 63 Combidex 63 ZYBRESTAT TM 63 chemotherapy induced neutropenia 63 docetaxel Taxotere 63 Inhalation Solution 63 sorafenib Nexavar ® 63 anakinra 63 dyskinesia PD LID 63 TRO# 63 Epirubicin 63 metastatic castration resistant 63 omega interferon 63 CEQ# 63 interferon alfa 2b 63 C1 INH 63 HBeAg positive patients 63 Azixa 63 huN# DM1 63 Thalomid ® 63 Imprime PGG 63 MoxDuo IR 63 patients evaluable 63 Targretin capsules 63 Xelox 63 bexarotene 63 APOPTONE 63 Omacetaxine 63 pegylated interferon alfa 2b 63 multicenter randomized placebo controlled 63 candidate AQ4N 63 phase Ib clinical 63 LibiGel ® 63 FOLFOX6 chemotherapy regimen 63 evaluating Actimmune 63 volociximab 63 RSD# iv 63 BiovaxID 63 vorinostat 63 Vidaza ® 63 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 63 TKI therapy 63 EDEMA4 63 pegylated interferon alpha 63 mRCC 63 mGluR5 negative 63 ribavirin Copegus ® 63 idarubicin 63 SCH # 63 Leukine ® 63 Trastuzumab 63 bortezomib Velcade 63 darapladib 63 PI3K/Akt pathway inhibitor 63 midstage clinical 63 carfilzomib 63 RSD# oral 63 Excellarate TM 63 Folfox 63 immunomodulatory therapy 63 concurrent chemoradiation 63 Camptosar ® 63 Cardio Vascu Grow 63 Locteron ® 63 AZILECT R 63 CR# vcMMAE 63 active moiety 63 dimebon 63 Copegus ® 63 Zenvia Phase III 63 pioglitazone HCl 63 BLP# Liposome Vaccine 63 PD LID 63 seliciclib 63 LE SN# 63 GRN#L 63 DMARDS 63 cytotoxic chemotherapy 63 mGluR5 NAM 63 mg kg dose 63 Mycamine 63 AVADO 63 Phase III clinical 63 ofatumumab 63 tocilizumab 63 EXPAREL TM 63 TRIOLEX HE# APOPTONE HE# 63 Pruvel 63 tesmilifene 63 K ras mutations 63 leukemia AML 63 ancrod 63 metaglidasen 63 Anturol ® 63 severe hypercholesterolemia 63 XL# anticancer compounds 63 Neurodex 63 intravenous methylnaltrexone 63 MERLIN TIMI 63 prospective randomized multicenter 63 afatinib 63 Dyloject TM 63 r hGH 63 ONCASPAR 63 IRX 2 63 GEM OS2 63 VPRIV 63 MYDICAR ® 63 Onconase 63 Iluvien ® 63 Perifosine 63 Onrigin 63 Ventavis 62 phase IIb III 62 telomerase therapeutic 62 intravenous acetaminophen 62 GAMMAGARD LIQUID 62 placebo controlled Phase III 62 OMS# 62 Aloxi injection 62 TYGACIL 62 Phase 2b trial 62 SNT MC# 62 castrate resistant prostate cancer 62 figitumumab 62 MEK inhibitor RDEA# 62 Phase III confirmatory 62 Canvaxin 62 ASA# 62 velafermin 62 Paraplatin ® 62 anidulafungin 62 Topical Interferon Alpha 2b 62 iclaprim 62 Dapagliflozin 62 CDK inhibitor 62 placebo controlled clinical 62 Zavesca R 62 REVLIMID ® 62 sitaxsentan 62 oral methylnaltrexone 62 Arcalyst 62 Phase IIa trials 62 stage IIIB 62 sunitinib 62 Elitek 62 Cellegesic 62 PEGASYS ® 62 Stimuvax R 62 Phase IIB 62 S1P antibody 62 Betaseron ® 62 RhuDex TM 62 melphalan prednisone 62 Alinia 62 targeted radiotherapeutic 62 Prestara TM 62 Parkinson disease levodopa induced 62 pitavastatin 62 Teysuno 62 ULORIC 62 CHOP chemotherapy 62 alefacept 62 AP# [003] 62 plus prednisone 62 EXPAREL 62 DU #b 62 octreotide 62 RIGScan CR 62 FTY# 62 LUCENTIS 62 brostallicin 62 recurrent metastatic 62 OMNARIS Nasal Spray 62 pain palliation 62 ALN PCS 62 PREOS R 62 Saxagliptin 62 Pegintron 62 RE SURGE 62 tenofovir emtricitabine 62 midstage studies 62 interferon alfa 62 viral kinetic 62 Amigal 62 Phase IIb clinical trials 62 IV Busulfex 62 GEM OS1 62 ZOSTAVAX 62 MEK inhibitor 62 Synavive 62 biologic DMARD 62 Study GL# 62 Ozarelix 62 Fx #A 62 TASKi3 62 investigational humanized monoclonal antibody 62 Eloxatin ® 62 metastatic hormone refractory 62 LymphoStat B TM 62 AAG geldanamycin analog 62 olmesartan 62 ELOXATIN 62 PROVENGE ® 62 L MTP PE 62 MT# MEDI 62 Factor VIIa 62 FOLFOX6 62 GALNS 62 TNF antagonists 62 non metastatic osteosarcoma 62 gemifloxacin 62 Ceflatonin 62 paclitaxel Taxol 62 mCRC patients 62 pegylated interferons 62 sunitinib Sutent 62 platelet inhibitor 62 otelixizumab 62 herpetic keratitis 62 Virulizin ® 62 gadobutrol 62 ganaxolone 62 Actimmune ® 62 PEGylated interferon beta 1a 62 topical diclofenac 62 TACI Ig 62 Neulasta R 62 INCB# [002] 62 Phase IIb clinical 62 VFEND 62 ZYVOX 62 voriconazole 62 MyVax 62 Xinlay 62 Tasimelteon 62 relapsing multiple sclerosis 62 Pyridorin 62 CORLUX CORT # 62 PEGylated Fab fragment 62 Huntexil 62 PF # [001] 62 multicenter Phase II 62 pegylated interferon alfa 62 TRANSDUR ® 62 systemic RNAi therapeutic 62 tremelimumab 62 NEUVENGE 62 gastrointestinal stromal tumors GIST 62 RSD# 62 CRx 62 Soliris TM eculizumab 62 peginterferon alfa 2b 62 ritonavir boosted 62 ILUVIEN ® 62 occlusion PAO 62 tobramycin 62 PEG interferon 62 orally administered inhibitor 62 myelodysplastic myeloproliferative diseases 62 Prestara 62 LUX Lung 62 oncolytic virus therapies 62 plus prednisone prednisolone 62 M Vax 62 BARACLUDE R 62 aripiprazole Abilify 62 temsirolimus Torisel ® 62 hA# 62 ATPace TM 62 monoclonal antibody IgG1 Mab 62 TransVax TM 62 bardoxolone 62 Phase 2b study 62 refractory AML 62 pegylated interferon alfa 2a 62 RhuDex 62 omacetaxine mepesuccinate 62 rALLy 62 MEK inhibitors 62 cancer immunotherapies 62 Vidaza azacitidine 62 ATL/TV# 62 TG# [003] 62 Ceflatonin ® 62 Onrigin TM 62 GTC recombinant human 62 T#I mutation 62 Phase 2a clinical 62 ospemifene 62 Vascular Wrap 62 recurrent GBM 62 pharmacodynamic properties 62 letrozole Femara 62 #I TM# 62 ADVEXIN clinical 62 double blinded randomized 62 heavily pretreated patients 62 Cloretazine VNP#M 62 ATTRACT 62 Cloretazine R 62 R Saizen R 62 desvenlafaxine succinate 62 mcg dose 62 oblimersen 62 personalized immunotherapy 62 Romidepsin 62 acetonide FA 62 Adlea 62 Cimzia TM 62 Solazed 62 PDE4 inhibitor 62 saline placebo 62 Tekturna HCT 62 novel histone deacetylase 62 confirmatory clinical 62 Catena ®